Hydrogel-supported optical-microcavity sensors
Hydrogel-supported optical-microcavity sensors
复制标题
DOI:
10.1002/adma.200500261
复制
发表时间:
2005-09-16
影响因子:
29.4
通讯作者:
Pentland, AA
中科院分区:
文献类型:
--
作者:
DeLouise, LA;Fauchet, PM;Pentland, AA
As the breadth of silicon-chip-based biomedical diagnostic (biosensors) and therapeutic (drug-delivery) technologies continues to expand, there exists a growing need to improve the biological±device interface for both in-vivo and ex-vivo applications. The biological±device interface sets operational constraints on the various mechanical, material, and preparatory aspects of how samples are collected, processed, and applied to a device, as well as on establishing requirements for device biocompatibility, tolerance towards biofouling, and the stability of immobilized bioreagents. Typically, siliconchip-based devices (5±10 μm thick), including microfluidic microelectromechanical systems (MEMS) devices, are fabricated from and remain attached to the rigid bulk-silicon wafer support (∼ 0.5±0.6 mm thick). This architecture may limit device function particularly for microfluidic porous structures, for which optimum function may depend on the directionality of flow through the device. Improving the biological±device interface could significantly advance the performance characteristics and versatility of chip-based devices while enabling new applications. For example, wound-care management could be advanced through the development of a ªsmart bandageº, which is conceptualized as an optical device (2±10 μm thick) embedded in a flexible, therapeutic support matrix (eg, polymeric gel). This architecture would improve the biological±device interface by enabling the ªsmart bandageº to